Superworth

Ardelyx EPS ARDX

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$0.22
Latest quarter, Q2 FY26
−$0.07
Fiscal year 2025
−$0.25

Ardelyx's earnings per share was −$0.22 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.07.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.25n/a
FY2024−$0.16n/a
FY2023−$0.30n/a
FY2022−$0.48n/a
FY2021−$1.26n/a
FY2020−$0.26n/a
FY2019−$0.37n/a
FY2018−$0.41n/a
FY2017−$0.34n/a
FY2016−$0.71n/a
FY2015−$0.28n/a
FY2014−$0.62n/a
FY2013−$1.40n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.07n/a−$0.22
Q1 FY26−$0.15n/a−$0.23
Q4 FY25$0.00−100%−$0.25
Q3 FY25$0.00n/a−$0.23
Q2 FY25−$0.08n/a−$0.23
Q1 FY25−$0.17n/a−$0.22
Q4 FY24$0.02n/a−$0.16
Q3 FY24$0.00−100%−$0.30
Q2 FY24−$0.07n/a−$0.27
Q1 FY24−$0.11n/a−$0.28
Q4 FY23−$0.12−300%−$0.30
Q3 FY23$0.03n/a−$0.12

Against its peers

Companies in Drug Manufacturers - General nearest Ardelyx's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ARDXArdelyx−$0.22
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
ARVNArvinas$0.16
PCRXPacira BioSciences$0.35
Peer median$0.85

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Ardelyx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.